Armistice Capital, LLC Re Shape Lifesciences Inc. Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.56 - $1.25 $80,074 - $178,738
142,991 New
142,991 $82,000
Q3 2021

Nov 15, 2021
SELL
$2.67 - $5.09 $2.18 Million - $4.16 Million
-816,527 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.02 - $7.64 $1.65 Million - $6.24 Million
816,527 New
816,527 $4.08 Million

About ReShape Lifesciences Inc.

RSLS Quotes by TradingView
  • Ticker RSLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,559,400
  • Market Cap $130M
  • Description
  • ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...
More about RSLS
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email